COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 58: Line 58:
* [[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]
* [[User:Hudakarman|Huda A. Karman M.D., M.P.H., M.S.]]
<br />
<br />
'''Pediatrics and COVID-19'''
* [[User:Harmeetkharoud91|Harmeet Kharoud, M.D,. MPH]]
'''Pulmonary Disorders and COVID-19 Team Members'''
'''Pulmonary Disorders and COVID-19 Team Members'''



Revision as of 02:51, 12 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief:

Cardiovascular Disorders of COVID-19 Team Members

Dermatologic Disorders of COVID-19 Team Members

Frequently Asked Inpatient Questions Team Members

Frequently Asked Outpatient Questions Team Members

Hematologic disorders of COVID-19 Team Members

Nephrologic Disorders of COVID-19 Team Members


Neurologic Disorders and COVID-19 Team Members

Ongoing Clinical Trials of COVID-19 Team Members


Pediatrics and COVID-19

Pulmonary Disorders and COVID-19 Team Members

  • Ayesha Farheen Javid


Radiologic Manifestations of COVID-19 Team Members


Other Team Members